Genetics Associates, Inc. TEST MENU CANCER/LEUKEMIA CHROMOSOME ANALYSIS TEST CPT CODES TAT Chromosome Analysis – Bone Marrow 88237 x 2, 88264, 88280 x 3, 88291 4 Days Chromosome Analysis – Bone Marrow Core 88237 x 2, 88264, 88280 x 3, 88291 4 Days Chromosome Analysis – Leukemic Blood 88237 x 2, 88264, 88280 x 3, 88291 4 Days Chromosome Analysis – Lymph Node 88233 x 2, 88264, 88280 x 3, 88291 4 Days Chromosome Analysis – Mass/Solid Tumor 88233 x 2, 88264, 88280 x 3, 88291 14 Days Chromosome Analysis – Peritoneal Fluid 88237 x 2, 88264, 88280 x 3, 88291 4 Days Chromosome Analysis – Pleural Fluid 88237 x 2, 88264, 88280 x 3, 88291 4 Days Chromosome Analysis – Fixed Pellet 88264, 88280 x 3, 88291 4 Days Chromosome Analysis – Fine Needle Aspirate 88237 x 1, 88264, 88280 x 3, 88291 4 Days FLUORESCENCE IN SITU HYBRIDIZATION (FISH) TEST CPT CODES TAT FISH - Single (Whole Specimen or Pellet) 88271 (per probe), 88275 (per probe), 88291 4 Days FISH – Single (Paraffin Embedded Tissue Slides) 88271 (per probe), 88275 (per probe), 88291 7 Days FISH – Multi - (Whole Specimen or Pellet) 88271 x 2 (per probe), 88275 (per probe), 88291 4 Days FISH – Multi - (Paraffin Embedded Tissue Slides) 88271 (per probe), 88275 (per probe), 88291 7 Days FISHnet / iFISH (enrichment only) 88112 (FISH codes will also apply—see above) 4 Days (See below for list of FISH probes by profile and in numerical order.) (FISH may be performed on the following specimen types: Bone Marrow, Bone Marrow Core, Fixed Pellets, Leukemic Blood, Lymph Node, Mass/Solid Tumor, Paraffin Embedded Tissue Slides, Pleural Fluid, Peritoneal Fluid, and Urine.) MKI 001.02 Effective 04-14-21 CANCER/LEUKEMIA FISH PROBES BY PROFILE Adult B-Cell ALL profile Adult T-Cell ALL profile del(9p) CDKN2A 14q11.2 TRA rearrangements del(6q) CCND3/SEC63/MYB 7q34 TRB rearrangements t(9;22) BCR/ABL1/ASS1 10q24 TKX1 11q23 KMT2A (MLL) rearrangements 5q35 TLX3 t(1;19) TCF3/PBX1 11q23 KMT2A (MLL) rearrangements 14q32 IGH rearrangements del(9p) CDKN2A Pediatric ALL profile (COG) Ph-Like ALL profile t(12;21) ETV6/RUNX1 1q25.2 ABL2 11q23 KMT2A (MLL) rearrangements 5q32 PDGFRB t(9;22) BCR/ABL1/ASS1 5q32 CSF1R trisomy 4,10,17 9p24.1 JAK2 14q32 IGH rearrangement 9q34.1 ABL1 Additional probes 19p13.2 EPOR t(1;19) TCF3/PBX1 Xp22.33/Yp11.3 CRFL2 Acute Myelogenous (AML) profile CLL Lymphocytic (CLL) profile t(15;17) PML/RARA (CD19+ Clones Available) t(9;22) BCR/ABL1/ASS1 del(11q) ATM t(8;21) RUNX1T1/RUNX1 trisomy 12 11q23 KMT2A (MLL) rearrangements del(13q) 13q14/13q34 inv(16), t(16;16) CBFB rearrangements del(17p) TP53 inv(3) MECOM rearrangements Additional Probes 17q RARA rearrangements t(11;14) CCND1/IGH NUP98 11p15 del(6q) CCND3/SEC63/MYB MKI 001.02 Effective 04-14-21 CANCER/LEUKEMIA Chronic Myelogenous (CML) profile Lymphoma probes t(9;22) BCR/ABL1/ASS1 (CD19+ Clones Available) Additional probes t(8;14) MYC/IGH (Burkitt or Follicular) trisomy 8 8q24 MYC rearrangements i(17q) t(11;14) CCND1/IGH (Mantle Cell) t(11;18) BIRC3/MALT1 18q21 BCL2 rearrangements 18q21 MALT1 rearrangements t(14;18) IGH/BCL2 (Follicular or Diffuse Large B-Cell) 3q27 BCL6 rearrangements (Diffuse Large B-Cell, Follicular Marginal Zone B-cell) T-cell Leukemia/Lymphoma probes Multiple Myeloma CD138 Enriched (MM) profile (FISHnet™) 2p23 ALK (Anaplastic) rearrangements 1p32.3/1q21 CDKN2C/CKS1B 14q11.2 TRA rearrangements del(13q) 13q14/13q34 7q34 TRB rearrangements del(17p) TP53 i(7q) 7cen/7q22/7q31 t(11;14) CCND1/IGH 14q32 TCL1A t(4;14) FGFR3/IGH 10q24 TLX1 t(14;16) IGH/MAF 5q35 TLX3 Additional probes trisomy 5 8q24 MYC rearrangements t(6;14) CCND3/IGH t(14;20) IGH/MAFB MKI 001.02 Effective 04-14-21 CANCER/LEUKEMIA Myelodysplastic (MDS) profile Myeloproliferative (MPN) profile del(5q) EGR1 del(5q) EGR1 del(7q) / monosomy 7 del(7q) / monosomy 7 trisomy 8 trisomy 8 del(20q) del(20q) Additional probes t(9;22) BCR/ABL1/ASS1 11q23 KMT2A (MLL) rearrangements Additional probes t(9;22) BCR/ABL1/ASS1 4q12 FIP1L1/CHIC2/PDGFRA NUP98 11p15 5q32 PDGFRB rearrangements 12p13 ETV6 rearrangements 8p11 FGFR1 rearrangements 9q24 JAK2 rearrangements Solid Tumor probes Transplant EWSR1 Ewing Sarcoma XX/XY for sex mismatched transplants FOXO1 Alveolar Rhabdomyosarcoma DDIT3 (CHOP) Myxoid Liposarcoma LOH 1p/19q Glioma MYCN 2p24.1 Neuroblastoma SS18 Synovial Sarcoma Bladder Cancer Screening (Trisomy 3, 7, 17, & 9p21 loss) MKI 001.02 Effective 04-14-21 CANCER/LEUKEMIA FISH PROBES NUMERICALLY Chromosome # Probe Location on Cancer Requisition 1 1p32.3/1q21 CDKN2C/CKS1B Multiple Myeloma Profile 1 1q25.2 ABL2 Ph Like ALL profile 1, 19 t(1;19) TCF3/PBX1 Adult B-Cell ALL profile Pediatric ALL profile 1, 19 1p/19q LOH (Glioma) Solid Tumor probes 2 2p23 ALK (Anaplastic) rearrangements T-cell Leukemia/Lymphoma probes 2 2p24.1 MYCN (Neuroblastoma) Solid Tumor probes 3 inv(3) MECOM rearrangements Acute Myelogenous (AML) profile 3 3q27 BCL6 rearrangements (Diffuse Large B-Cell, Follicular, Lymphoma probes Marginal Zone B-cell) 4, 10, 17 trisomy 4,10,17 Pediatric ALL profile 4 4q12 FIP1L1/CHIC2/PDGFRA Myeloproliferative (MPN) profile 4, 14 t(4;14) FGFR3/IGH Multiple Myeloma Profile 5 del(5q) EGR1 / trisomy 5 Multiple Myeloma Profile Myeloproliferative (MPN) profile Myelodysplastic (MDS) profile 5 5q33 PDGFRB rearrangements Multiple Myeloma Profile Ph Like ALL Profile 5 5q32 CSF1R Ph Like ALL Profile 5 5q35 TLX3 Adult T-Cell ALL profile MKI 001.02 Effective 04-14-21 CANCER/LEUKEMIA Chromosome # Probe Location on Cancer Requisition 6 del(6q) CCND3/SEC63/MYB Adult B-Cell ALL profile Chronic Lymphocytic (CLL) profile 6, 14 t(6;14) CCND3/IGH Multiple Myeloma Profile 7 del(7q) / monosomy 7 / trisomy 7 Multiple Myeloma Profile Myelodysplastic (MDS) profile Myeloproliferative (MPN) profile 7 i(7q) 7cen/7q22/7q31 T-cell Leukemia/Lymphoma probes 7 7q34 TRB rearrangements Adult T-Cell ALL profile T-cell Leukemia/Lymphoma probes 8 trisomy 8 (CHARGE) Chronic Myelogenous (CML) profile Myelodysplastic (MDS) profile Myeloproliferative (MPN) profile 8 8p11 FGFR1 rearrangements Myeloproliferative (MPN) profile 8 8q24 MYC rearrangements Lymphoma probes 8,14 t(8;14) MYC/IGH (Burkitt or Follicular) Lymphoma probes 8, 21 t(8;21) RUNX1T1/RUNX1 Acute Myelogenous (AML) profile 9 9p24 JAK2 rearrangements Myeloproliferative (MPN) profile 9 del(9p) CDKN2A Adult B-Cell ALL profile Adult T-Cell ALL profile 9 9q34.1 ABL1 Ph Like ALL Profile MKI 001.02 Effective 04-14-21 CANCER/LEUKEMIA Chromosome # Probe Location on Cancer Requisition 9, 22 t(9;22) BCR/ABL1/ASS1 Adult B-Cell ALL profile Pediatric ALL profile Acute Myelogenous (AML) profile Chronic Myelogenous (CML) profile Myelodysplastic (MDS) profile Myeloproliferative (MPN) profile 10 10q24 TLX1 Adult T-Cell ALL profile T-cell Leukemia/Lymphoma probes 11 NUP98 11p15 Acute Myelogenous (AML) profile Myelodysplastic (MDS) profile 11 del(11q) ATM Chronic Lymphocytic (CLL) profile 11 11q23 KMT2A (MLL) rearrangements Myelodysplastic (MDS) profile Adult B-Cell ALL profile Adult T-Cell ALL profile Pediatric ALL profile Acute Myelogenous (AML) profile 11, 14 t(11;14) CCND1/IGH Chronic Lymphocytic (CLL) profile t(11;14) CCND1/IGH (Mantle Cell) Lymphoma probes t(11;14) CCND1/IGH Multiple Myeloma Profile 11, 18 t(11;18) BIRC3/MALT1 Lymphoma probes 12 trisomy 12 Chronic Lymphocytic (CLL) profile 12 12p13 ETV6 rearrangements Myelodysplastic (MDS) profile 12 12q13 DDIT3 (CHOP) Myxoid Liposarcoma Solid Tumor probes MKI 001.02 Effective 04-14-21 CANCER/LEUKEMIA Chromosome # Probe Location on Cancer Requisition 12, 21 t(12;21) ETV6/RUNX1 Pediatric ALL profile 13 del(13q) 13q14/13q34 Chronic Lymphocytic (CLL) profile Multiple Myeloma Profile 13 13q14.1 FOXO1 Alveolar Rhabdomyosarcoma Solid Tumor probes 14 14q11.2 TRA rearrangements Adult T-Cell ALL profile T-cell Leukemia/Lymphoma probes 14 14q32 IGH rearrangements Adult B-Cell ALL profile Pediatric ALL profile 14 14q32 TCL1A T-cell Leukemia/Lymphoma probes 14, 16 t(14;16) IGH/MAF Multiple Myeloma Profile 14, 18 t(14;18) IGH/BCL2 (Follicular or Diffuse Large B-Cell) Lymphoma probes 14, 20 t(14;20) IGH/MAFB Multiple Myeloma Profile 15, 17 t(15;17) PML/RARA Acute Myelogenous (AML) profile 16 inv(16), t(16;16) CBFB rearrangements Acute Myelogenous (AML) profile 17 del(17p) TP53 Chronic Lymphocytic (CLL) profile del(17p) TP53 Multiple Myeloma Profile 17 i(17q) Chronic Myelogenous (CML) profile 17 17q RARA rearrangements Acute Myelogenous (AML) profile 18 18q11.2 SS18 Synovial Sarcoma Solid Tumor probes 18 18q21 BCL2 rearrangements Lymphoma probes 18 18q21 MALT1 rearrangements Lymphoma probes 19 19p13.2 EPOR Ph Like Profile MKI 001.02 Effective 04-14-21 CANCER/LEUKEMIA Chromosome # Probe Location on Cancer Requisition 20 del(20q) Myelodysplastic (MDS) profile Myeloproliferative (MPN) profile 22 22q12.2 EWSR1 Ewing Sarcoma Myeloproliferative (MPN) profile 3, 7, 9, 17 Bladder Cancer Screening Solid Tumor probes X/Y CEPXY (XX/XY for sex mismatched transplant) Transplant X/Y Xp22.33/Yp11.3 CRFL2 Ph Like ALL Profile CHROMOSOME MICROARRAY TEST CPT CODES TAT Microarray (SNP) 81229 10 Days NEXT GENERATION SEQUENCING (NGS) TEST CPT CODES TAT NGS 81450 14 Days (See below for list of NGS panels.) Panel Included Genes AML Molecular Profile ASXL1, CBL, CEBPA, CSF3R, DNMT3A, EZH2, IDH1, IDH2, JAK2, KIT, MPL, NPM1, NRAS, RUNX1, SETBP1, SF3B1, SRSF2, TET2, TP53, U2AF1 MDS Molecular Profile ASXL1, EZH2, DNMT3A, RUNX1, SF3B1, SRSF2, TET2, TP53, U2AF1 MPN Molecular Profile ABL1, CALR, CSF3R, EZH2, JAK2, MPL, SETBP1 MPN Targeted Molecular Profile JAK2, MPL, CALR Myeloid Complete Molecular Profile ABL1, ASXL1, BRAF, CALR, CBL, CEBPA, CSF3R, DNMT3A,